Katy Sakamoto

Svp, Technology Operations at MedMen

Katy Sakamoto has a comprehensive work experience spanning across multiple industries. Katy currently holds the position of SVP, Technology Operations at MedMen since April 2019. Prior to this, they worked at Rival Inc as Director, Operations from December 2017 to April 2019. Katy also served as Director, Operations at Whisper from June 2014 to March 2017, as well as at Clinkle from October 2013 to April 2014. Katy Sakamoto's career journey includes their role as Director, Business Operations at Nimbula from October 2010 to September 2013. Katy began their professional career as an Analyst at Sequoia Capital from October 2007 to September 2010. Prior to entering the technology sector, they gained experience as a Senior Litigation Legal Assistant at Howard Rice Nemerovski Canady Falk & Rabkin from October 2003 to September 2007. Overall, Katy Sakamoto possesses a diverse set of skills and knowledge acquired through their various roles in both operations and technology fields.

Katy Sakamoto has attended Colgate University, but there is no information available regarding the specific years of attendance, degree obtained, or field of study pursued.

Location

Los Angeles, United States

Links

Previous companies


Org chart


Teams


Offices


MedMen

11 followers

MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations nationwide. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is the most recognized cannabis brand in the world today. Based in Los Angeles, MedMen employs over 1,100 team members across the U.S. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to redefine our society's relationship with cannabis. The federal prohibition has had a disastrous impact, overpopulating our prisons and enriching violent drug cartels while keeping a relatively benign substance with proven benefits out of the reach of law abiding citizens.


Industries

Employees

1,001-5,000

Links